Brief: Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million
05/08/2026 21:02
BRIEF-Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million Aug 05 (Reuters) - Editas Medicine Q2 operating expenses USD 30.444 million.
- Q2 operating income USD -18.554 million
- Q2 basic EPS USD -0.15
- Q2 collaboration and other research and development revenue USD 11.9 million
- Q2 EPS USD -0.15
Recent news on Editas Medicine
See all newsEditas Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Editas Medicine, Inc. expected to post a loss of 27 cents a share - Earnings Preview
Editas Medicine Q2 net loss narrows and beats estimates
Brief: Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million
Editas Medicine down after $125 mln stock-and-warrants offering